BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21352112)

  • 21. [Acute psychiatric diseases].
    Meder J; Jarema M; Adamska-Wegrzyn E; Habrat B; Heitzman J; Koszewska I; Parnowski T; Szafrański T; Woźniak A
    Psychiatr Pol; 2007; 41(6):871-938. PubMed ID: 18540429
    [No Abstract]   [Full Text] [Related]  

  • 22. A national study of violent behavior in persons with schizophrenia.
    Swanson JW; Swartz MS; Van Dorn RA; Elbogen EB; Wagner HR; Rosenheck RA; Stroup TS; McEvoy JP; Lieberman JA
    Arch Gen Psychiatry; 2006 May; 63(5):490-9. PubMed ID: 16651506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated treatment ameliorates negative symptoms in first episode psychosis--results from the Danish OPUS trial.
    Thorup A; Petersen L; Jeppesen P; Ohlenschlaeger J; Christensen T; Krarup G; Jørgensen P; Nordentoft M
    Schizophr Res; 2005 Nov; 79(1):95-105. PubMed ID: 16122909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ten-year follow-up of the OPUS specialized early intervention trial for patients with a first episode of psychosis.
    Secher RG; Hjorthøj CR; Austin SF; Thorup A; Jeppesen P; Mors O; Nordentoft M
    Schizophr Bull; 2015 May; 41(3):617-26. PubMed ID: 25381449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substance abuse and schizophrenia: which comes first?
    Expert Rev Neurother; 2006 Apr; 6(4):453-4. PubMed ID: 16623644
    [No Abstract]   [Full Text] [Related]  

  • 26. The Lambeth Early Onset Crisis Assessment Team Study: general practitioner education and access to an early detection team in first-episode psychosis.
    Power P; Iacoponi E; Reynolds N; Fisher H; Russell M; Garety P; McGuire PK; Craig T
    Br J Psychiatry Suppl; 2007 Dec; 51():s133-9. PubMed ID: 18055931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Auditing first episode psychosis: giving meaning to clinical governance.
    Rowlands RP
    Int J Clin Pract; 2001 Dec; 55(10):669-72. PubMed ID: 11777290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.
    Arendt M; Mortensen PB; Rosenberg R; Pedersen CB; Waltoft BL
    Arch Gen Psychiatry; 2008 Nov; 65(11):1269-74. PubMed ID: 18981338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Group intervention for coexisting psychosis and substance use disorders in rural Australia: outcomes over 3 years.
    Bradley AC; Baker A; Lewin TJ
    Aust N Z J Psychiatry; 2007 Jun; 41(6):501-8. PubMed ID: 17508320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substance misuse and psychosis.
    Poole R; Brabbins C
    Br J Hosp Med; 1997 Nov 5-18; 58(9):447-50. PubMed ID: 9619206
    [No Abstract]   [Full Text] [Related]  

  • 31. [Inhalant abusers and psychiatric symptoms].
    Okudaira K; Yabana T; Takahashi H; Iizuka H; Nakajima K; Saito A
    Seishin Shinkeigaku Zasshi; 1996; 98(4):203-12. PubMed ID: 8710994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. National Institute for Health and Clinical Excellence (NICE) guideline: psychosis with coexisting substance misuse.
    Abou Saleh M; Crome I
    Addiction; 2012 Jan; 107(1):1-3. PubMed ID: 21939460
    [No Abstract]   [Full Text] [Related]  

  • 33. Achieving effective treatment of patients with chronic psychotic illness and comorbid substance dependence.
    Ho AP; Tsuang JW; Liberman RP; Wang R; Wilkins JN; Eckman TA; Shaner AL
    Am J Psychiatry; 1999 Nov; 156(11):1765-70. PubMed ID: 10553741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders.
    Drake RE; McHugo GJ; Xie H; Fox M; Packard J; Helmstetter B
    Schizophr Bull; 2006 Jul; 32(3):464-73. PubMed ID: 16525088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Danish OPUS Early Intervention Services for First-Episode Psychosis: A Phase 4 Prospective Cohort Study With Comparison of Randomized Trial and Real-World Data.
    Posselt CM; Albert N; Nordentoft M; Hjorthøj C
    Am J Psychiatry; 2021 Oct; 178(10):941-951. PubMed ID: 34315283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five years of specialised early intervention versus two years of specialised early intervention followed by three years of standard treatment for patients with a first episode psychosis: randomised, superiority, parallel group trial in Denmark (OPUS II).
    Albert N; Melau M; Jensen H; Emborg C; Jepsen JR; Fagerlund B; Gluud C; Mors O; Hjorthøj C; Nordentoft M
    BMJ; 2017 Jan; 356():i6681. PubMed ID: 28082379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Recovery and Long-Term Association of Specialized Early Intervention Services vs Treatment as Usual Among Individuals With First-Episode Schizophrenia Spectrum Disorder: 20-Year Follow-up of the OPUS Trial.
    Hansen HG; Starzer M; Nilsson SF; Hjorthøj C; Albert N; Nordentoft M
    JAMA Psychiatry; 2023 Apr; 80(4):371-379. PubMed ID: 36811902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of an early psychosis program on substance use.
    Addington J; Addington D
    Psychiatr Rehabil J; 2001; 25(1):60-7. PubMed ID: 11529454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of five years versus two years of specialised assertive intervention for first episode psychosis - OPUS II: study protocol for a randomized controlled trial.
    Melau M; Jeppesen P; Thorup A; Bertelsen M; Petersen L; Gluud C; Krarup G; Nordentoft M
    Trials; 2011 Mar; 12():72. PubMed ID: 21392377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of early intervention in first-episode psychosis: economic evaluation of a randomised controlled trial (the OPUS study).
    Hastrup LH; Kronborg C; Bertelsen M; Jeppesen P; Jorgensen P; Petersen L; Thorup A; Simonsen E; Nordentoft M
    Br J Psychiatry; 2013 Jan; 202(1):35-41. PubMed ID: 23174515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.